Palliative treatment of malignant hilar biliary strictures is difficult, especially when the stricture involves both the right and left hepatic ducts (Bismuth types II and higher). Drainage of both ductal sys− tems is desirable because there is a risk of cholangitis after endoscopic biliary in− tervention if drainage is incomplete [1,2]. The rates for mean survival, 30−day mor− tality, and death from sepsis in patients with Klatskin tumors are reported to be significantly better with bilateral self−ex− panding metal stents (SEMS) compared with unilateral stents [3]. Endoscopic placement of two parallel SEMS is techni− cally demanding. To circumvent this problem, a "Y" stent has been designed which consists of two uncovered SEMS (Niti−S Biliary stent, Y type [Endoscopic approach]; TaeWoong Medical Co. Ltd., Kyonggi−Do, South Korea): the first SEMS has a radiologically marked segment with wider mesh holes in its middle part, through which the second stent is deliv− ered on the other side (Figure 1). We re− port a case of hilar cholangiocarcinoma (Bismuth type III), which was successfully palliatively treated using this biliary Y stent.A 66−year−old woman presented with jaundice of 3 weeks duration, and with weight loss and pruritus. Abdominal com− puted tomography confirmed the exis− tence of a hilar mass, which was surgical− ly unresectable. Endoscopic retrograde cholangiopancreatography revealed hilar cholangiocarcinoma with a Bismuth type III anatomical configuration (Figure 2). A guide wire (0.035−inch Jagwire; Microva− sive Boston Scientific, Natick, Massachu− setts, USA) was negotiated into the right biliary system. The first SEMS was de− ployed over this guide wire, with the wider mesh holes positioned below the bifurcation. A second Jagwire was then passed through the gap in the first SEMS into the left ductal system, over which the second SEMS was deployed in a "Y" fashion ( Figure 3). This is the first case re− port describing the placement of a Y bili− ary stent in a hilar biliary stricture. The patient was jaundice− and pruritis−free 10 weeks after the procedure. The Y stent appears to represent a technically easier option for the managment of malignant hilar biliary strictures.